Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Herrmann

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Bone Marrow Transplantation|October 1, 1993
The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantationL A Smyth, C S Witt, F T Christiansen, et al.
Cancer|November 1, 1977
Angioimmunoblastic lymphadenopathy with dysproteinemiaL R Matz, J M Papadimitriou, J R Carroll, et al.
Cancer Treatment Reports|December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.
British Journal of Haematology|September 1, 1999
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphomaR E Brouwer, E Vellenga, K H Zwinderman, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Bone Marrow Transplantation|October 1, 1993
The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantationL A Smyth, C S Witt, F T Christiansen, et al.
Cancer|November 1, 1977
Angioimmunoblastic lymphadenopathy with dysproteinemiaL R Matz, J M Papadimitriou, J R Carroll, et al.
Cancer Treatment Reports|December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.
British Journal of Haematology|September 1, 1999
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphomaR E Brouwer, E Vellenga, K H Zwinderman, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Pageof 5